Rajputana Bio. Q3 FY26 Earnings Analysis

Published 6 Aug 2026 | Chemicals & Petrochemicals | Market Cap: ₹141 Cr

Price

200

Market Cap

₹141 Cr

P/E Ratio

15.5

Revenue Rank

Rank 1

Margin Rank

Rank 3

Earnings Summary

- Rajputana Biodiesel aims to operate at nearly 100% capacity at its enhanced Indian units next year. - Company aims to run enhanced capacities at almost 100% next year, targeting 130-150 kiloliters per day biodiesel production from April FY27.

📊 Revenue & Sales Performance

Rank 1

- Rajputana Biodiesel aims to operate at nearly 100% capacity at its enhanced Indian units next year. - The company plans to start civil work for a 150 kiloliters per day biodiesel plant in the GCC region by January-end 2026. - They intend to tap the marine fuel blending market with 24% biodiesel blending mandatory from January 2028 in GCC. - The CBG (Compressed Biogas) unit will begin with a 10 tons per day capacity in Rajasthan, targeting high EBITDA margins of 65%-70%. - The company expects to grow vertically and horizontally across biodiesel, biomass pellets, and CBG sectors, becoming a one-stop renewable energy solution provider. - They have bid for the highest tender volume in company history, with supply expected by March next year. - Revenue growth is expected from expanded capacities, diversified product segments, and entry into lucrative GCC and export markets.

📈 Profitability & Margins

Rank 3

- Company aims to run enhanced capacities at almost 100% next year, targeting 130-150 kiloliters per day biodiesel production from April FY27. - Bid for highest volume ever in OMC biodiesel tender for Nov-Mar 2026 period, awaiting allocations. - Expanding into GCC region capturing Europe's 14% biodiesel blending mandate and marine VLSFO fuel blending mandate (24% biodiesel by 2028). - Vertical integration with CBG and biomass pellets, targeting high EBITDA margins (CBG EBITDA 65-75%). - Plans to diversify into Sustainable Aviation Fuel long term. - H2 FY26 numbers expected heavier than H1, indicating revenue and profit growth. - Company confident of sustaining and growing profitability due to own feedstock (leading to cost advantages). - Strategic expansions and product diversification aimed at long-term value creation and steady profit margin improvements.

🏗️ Capital Expenditure Plans

Yes

- Acquisition of 262-acre land parcel for planting own feedstock (Napier grass) for compressed biogas (CBG) production, expected to register by January end; civil work for CBG project to commence by January. - Civil work to start by January for a new biodiesel unit in the GCC region (Middle East) targeting the European Union and marine fuel blending markets; location mostly finalized and awaiting regulatory approvals. - Expansion of current biodiesel capacities in India by 3 to 4 times; plans to run enhanced capacity near 100% utilization next year. - Preferential share issuance planned to raise funds for GCC biodiesel and CBG units; promoters to participate as well. - Diversification into biomass pellets production (solid segment) with a 50-75 tons/day pellet unit under development. Overall, the company is investing in vertical and horizontal growth across biodiesel, CBG, and pellet sectors with clear timelines for 2026.

💰 Fundraising & Capital Structure

Yes

- Rajputana Biodiesel Limited plans to raise funds through a preferential equity round for the GCC biodiesel unit and the CBG unit. - The company intends to use both its own capital and external funds in this preferential round. - No specific details on debt fundraising were mentioned in the transcript. - The preferential round is aimed at financing new capacity expansions and projects, including the CBG and GCC biodiesel plants.

📋 Order Book & Pipeline

No information

- Rajputana Biodiesel Limited has bid for the highest volume ever in the company's history in the current OMC biodiesel tender for November 2025 to March 2026. - Exact order quantity and price details are not disclosed due to restrictions on sharing unpublished sensitive information. - Supply of these tendered volumes is expected by March 2026 upon receiving allocations. - The company expects to operate at near 100% capacity of its enhanced production units in the next year. - They have also received approvals for establishing two compressed biogas (CBG) units and a biodiesel unit in the GCC region aimed to tap export and international markets.

Key Metrics

Revenue

Rank 1

Margin

Rank 3

Capex

Yes

Fundraise

Yes

Order Book

No information

Frequently Asked Questions

What were Rajputana Bio. Q3 FY26 results?

- Rajputana Biodiesel aims to operate at nearly 100% capacity at its enhanced Indian units next year. - Company aims to run enhanced capacities at almost 100% next year, targeting 130-150 kiloliters per day biodiesel production from April FY27.

What is Rajputana Bio. share price analysis?

Rajputana Bio. currently shows a strong growth signal based on ranking data. The stock trades at a P/E of 15.5 with a market cap of ₹141. Investors should review the full earnings analysis for detailed insights.

Is Rajputana Bio. planning capital expenditure?

- Acquisition of 262-acre land parcel for planting own feedstock (Napier grass) for compressed biogas (CBG) production, expected to register by January end; civil work for CBG project to commence by January.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.

Others in Chemicals & Petrochemicals this season

  • Indian Emuls (Q3 FY26)

    Indian Emuls Q3 FY26 quarterly results analysis. - For FY '26, the company expects revenue growth upward of 100%, with projections between 150% to 200% growth c

  • Tatva Chintan Pharma Chem Ltd (Q3 FY26)

    Tatva Chintan Q3 FY26 quarterly results analysis. - **SDA Segment**: Strong volume uptick expected from 2026 onward as new customers onboard; pricing bottomed o

  • Clean Science & Technology Ltd (Q3 FY26)

    Clean Science Q3 FY26 quarterly results analysis. - HALS segment expected to continue growing quarter-on-quarter, with 25% volume growth already seen in Q2 and

  • Laxmi Organic Industries Ltd (Q3 FY26)

    Laxmi Organic Q3 FY26 quarterly results analysis. - Laxmi Organic is focused on growth despite a demanding global chemical industry backdrop with regional overc